Blood collection systems including an integral, flexible filter

ABSTRACT

Blood collection systems include an integral flexible filter to remove leukocytes from blood components.

RELATED APPLICATION

This application is a continuation-in-part of U.S. patent applicationSer. No. 08/697,270, filed Aug. 21, 1996 (now U.S. Pat. No. 6,032,807),which is incorporated herein by reference, which is a continuation ofU.S. patent application Ser. No. 08/558,458, filed Nov. 16, 1995 (nowabandoned), which is a continuation of U.S. patent application Ser. No.08/392,297, filed Feb. 22, 1995 (now abandoned), which is a continuationof U.S. patent application Ser. No. 08/173,608, filed Dec. 22, 1993 (nowabandoned).

FIELD OF THE INVENTION

The invention generally relates to blood collection and processingsystems and methods.

BACKGROUND OF THE INVENTION

Systems composed of multiple, interconnected plastic bags have metwidespread use and acceptance in the collection, processing and storageof blood components. Using these systems, whole blood is collected andseparated into its clinical components (typically red blood cells,platelets, and plasma). The components are individually stored and usedto treat a multiplicity of specific conditions and diseased states.

Before storing blood components for later transfusion, it is believed tobe desirable to minimize the presence of impurities or other materialsthat may cause undesired side effects in the recipient. For example,because of possible reactions, it is generally considered desirable toremove substantially all the leukocytes from blood components beforestorage, or at least before transfusion.

Filtration is conventionally used to accomplish leuko-reduction. Systemsand methods for reducing the number of leukocytes by filtration inmultiple blood bag configurations are described, e.g., in Stewart U.S.Pat. No. 4,997,577, Stewart et al. U.S. Pat. No. 5,128,048, Johnson etal. U.S. Pat. No. 5,180,504, and Bellotti et. al. U.S. Pat. No.5,527,472.

SUMMARY OF THE INVENTION

The invention provides a blood collection system comprising a containerfor holding blood and a filter communicating with the container. Thefilter includes first and second flexible sheets comprising a meltablematerial and a depth filter medium comprising a meltable material. Aperipheral seal joins the sheets directly to the filter medium toencapsulate the filter medium between the first and second sheets. Theseal comprises a commingled melted matrix comprising material of thesheets and material of the filter medium.

In a preferred embodiment, the filter medium removes leukocytes fromblood.

Other features and advantages of the invention will become apparent uponreview of the following description, drawings, and appended claims.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic view of a blood collection and storage system thatincludes an integral flexible filter that removes leukocytes from redblood cells;

FIG. 2 is an exploded perspective view of the integral flexible filterthat forms a part of the system shown in FIG. 1, showing inlet andoutlet ports that pass through the unitary peripheral seal;

FIG. 3 is an assembled perspective view of the integral flexible filtershown in FIG. 2;

FIG. 4 is an assembled perspective view of an alternative embodiment ofan integral flexible filter that can form a part of the system shown inFIG. 1, showing inlet and outlet ports that do not pass through theunitary peripheral seal;

FIG. 5 is a perspective diagrammatic view showing a pre-assembled formof the integral flexible filter shown in FIG. 2, being assembled fromcontinuous roll stock;

FIG. 6 is a side section view of the preassembled form of the integralflexible filter shown in FIG. 5, as it passes between two spaced apartradio frequency energy dies;

FIG. 7 is a side section view of the pre-assembled form of the integralflexible filter shown in FIG. 6, engaged by the dies, which apply radiofrequency energy to form a unitary peripheral seal;

FIG. 8 is a top view of multiple sealed filter assemblies that aresequentially formed and die cut into individual filters 20 that can beintegrated into the system shown in FIG. 1;

FIG. 9 is a schematic view of a blood collection and storage system thatincludes an integral flexible filter that removes leukocytes from redblood cells, with a by pass channel for venting air around the filter;

FIG. 10 is a schematic view of a blood collection and storage systemthat includes an integral flexible filter that removes leukocytes fromred blood cells, with an integral air venting bag;

FIG. 11 is a schematic view of a blood collection and storage systemthat includes two integral flexible filters, one to remove leukocytesfrom red blood cells and the other to remove leukocytes fromplatelet-rich plasma; and

FIG. 12 is a schematic view of a blood collection and storage systemthat includes an integral flexible filter that removes leukocytes fromwhole blood prior to centrifugal processing.

The invention is not limited to the details of the construction and thearrangements of parts set forth in the following description or shown inthe drawings.

The invention can be practiced in other embodiments and in various otherways. The terminology and phrases are used for description and shouldnot be regarded as limiting.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

FIG. 1 shows a manual blood collection and storage system 10 having anintegral flexible filter 20. The system 10 provides red blood cells forlong term storage that are substantially free of leukocytes. The system10 also provides platelet concentrate and the platelet-poor plasma forlong term storage. The blood collection and storage assembly 10, oncesterilized constitutes a sterile, “closed” system, as judged by theapplicable standards in the United States. The system 10 is adisposable, single use item.

As shown in FIG. 1, the system 10 includes a primary bag 12 and threetransfer bags or containers 14, 16, and 18. Like the flexible filter 20,the transfer bags 14, 16, and 18 are integrally attached to the system10. In use, the system 10 is manipulated in conventional ways. Theprimary bag 12 (which is also called a donor bag) receives whole bloodfrom a donor through integrally attached donor tube 22 that carries anphlebotomy needle 24. A suitable anticoagulant A is contained in theprimary bag 12. The whole blood is centrifugally separated by conventionmeans inside the primary bag 12 into red blood cells and platelet-richplasma. Leukocytes dwell in the interface between the red blood cellsand platelet-rich plasma.

The transfer bag 14 is intended to receive platelet-rich plasmaseparated from the whole blood collected in the primary bag 12. Attemptsare made when transferring the platelet-rich plasma out of the primarybag 12 to keep as many leukocytes in the primary bag 12 as possible. Thetransfer of platelet-rich plasma into the transfer bag 14 leaves the redblood cells and the leukocytes behind in the primary bag 12.

The transfer bag 16 contains a suitable storage solution S for red bloodcells. One such solution is disclosed in Grode et al U.S. Pat. No.4,267,269, which is sold by Baxter Healthcare Corporation under thebrand name ADSOL® Solution. The storage solution S is transferred intothe primary bag 12 after transfer of the platelet-rich plasma into thetransfer bag 14.

The platelet-rich plasma is centrifugally separated by conventionalmeans in the transfer bag 14 into platelet concentrate and platelet-poorplasma. The platelet-poor plasma is transferred into the transfer bag16, which is now emptied of storage solution S. The transfer bag 16serves as the storage container for the platelet-poor plasma. Thetransfer bag 14 serves as its storage container for the plateletconcentrate.

The storage solution S is mixed with the red blood cells and leukocytesremaining in the primary bag 12. The mixture of storage solution S, redblood cells, and leukocytes is transferred from the primary bag 12through tubing 26. The tubing 26 carries in-line the integral, flexiblefilter 20. The flexible filter 20 includes a filtration medium 28contained within a housing 30. The filtration medium is selected toremove leukocytes from red blood cells.

The leukocyte-reduced red blood cells enter the transfer bag 18. Thetransfer bag 18 serves as the storage container for theleukocyte-reduced red blood cells.

The bags and tubing associated with the processing system 10 can all bemade from conventional approved medical grade plastic materials, such aspolyvinyl chloride plasticized with di-2-ethylhexyl-phthalate(PVC-DEHP). The bags are formed using conventional heat sealingtechnologies, e.g., radio frequency (RF) heat sealing.

Alternatively, since the transfer bag 14 is intended to store theplatelet concentrate, it can be made of polyolefin material (asdisclosed in Gajewski et al U.S. Pat. No. 4,140,162) or a polyvinylchloride material plasticized with tri-2-ethylhexyl trimellitate(TEHTM). These materials, when compared to DEHP-plasticized polyvinylchloride materials, have greater gas permeability that is beneficial forplatelet storage.

The flexible filter 20, like the rest of the system 10, is a disposable,single use item. Also, like the rest of the system 10, the filterhousing 30 is made using conventional approved medical grade plasticmaterials. Furthermore, like the rest of the system 10, the filterhousing 30 is formed using conventional radio frequency heat sealingtechnology. The filter 20, being flexible, facilitates handling andreduces the incidence of damage to other components of the system 10during centrifugal processing.

In the illustrated embodiment (see FIG. 2), the filter housing 30comprising first and second sheets 32 and 34 of medical grade plasticmaterial, such as polyvinyl chloride plasticized withdi-2-ethylhexyl-phthalate (PVC-DEHP). Other medical grade plasticmaterials can be used that are not PVC and/or are DEHP-free, providedthat the material heats and flows when exposed to radio frequencyenergy.

The filtration medium 28 is made from a fibrous material, which issandwiched between the sheets 32 and 34. The filtration medium 28 can bearranged in a single layer or in a multiple layer stack. The medium 28can include melt blown or spun bonded synthetic fibers (e.g., nylon orpolyester or polypropylene), semi-synthetic fibers, regenerated fibers,or inorganic fibers. In use, the medium 28 removes leukocytes by depthfiltration.

In the illustrated embodiment, the filtration medium 28 comprises, inthe blood flow direction, a prefilter region, a main filter region, anda postfilter region. The prefilter and postfilter are made of fibrousmaterial (e.g., polyethylene) having a pore size and fiber diameter notsuited for leukocyte removal. Instead, the fibrous material of theprefilter is sized to remove gross clots and aggregations present in theblood. The fibrous material of the postfilter is sized to provide afluid manifold effect at the outlet of the filter. In a representativeembodiment, the prefilter material has a pore size of between about 15μm to about 20 μm, and the postfilter material has a pore size of about20 μm. The main filter region is made of a fibrous material (e.g.,polyethylene) having a pore size and diameter sized to remove leukocytesby depth filtration. The material of the main filter region can have thecharacteristics described in Watanabe et al. U.S. Pat. No. 4,701,267 orNishimura et al. U.S. Pat. No. 4,936,998, which are incorporated hereinby reference.

According to the invention, a unitary peripheral seal 36 is formed bythe application of pressure and radio frequency heating in a singleprocess to the two sheets 32 and 34 and filtration medium 28. The seal36 joins the two sheets 32 and 34 to each other, as well as joins thefiltration medium 28 to the two sheets 32 and 34. The seal 36 integratesthe material of the filtration medium 28 and the material of the plasticsheets 32 and 34, for a reliable, robust, leak-proof boundary.

The filter 20 also includes inlet and outlet ports 38 and 40. The ports38 and 40 comprise tubes made of medical grade plastic material, likePVC-DEHP. As FIG. 3 shows, the ports 38 and 40 can be located in theintegrated peripheral seal 36, and be sealed in place at the same timethat the unitary peripheral seal 36 is formed. Alternatively (see FIG.4), the ports 38 and 40 can be inserted and sealed to each sheet 32 and34 in a separate assembly process before the unitary peripheral seal isformed, in the manner shown in Fischer et al. U.S. Pat. No. 5,507,904.Still alternatively, the ports 38 and 40 can comprise separately moldedparts that are heat sealed by radio frequency energy over a hole formedin the sheets.

The filter 20 (see FIG. 5) is formed from roll stock 42 and 44 of thefirst and second plastic sheets 32. The layer or layers of filtrationmedium 28 are also supplied from roll stock 46. The roll stock 42, 44,and 46 supply a continuous, layered filter pre-assembly 48.

The pre-assembly 48 is advanced in measured steps between a pair ofopposed dies 50 and 52 (see FIG. 6). Between each step, the opposed dies50 and 52 are moved together (see FIG. 7), to apply pressure to pressthe peripheral edge of the pre-assembly 48 together. Preferably a stop54 is provided to accurately space the dies 50 and 52 apart from eachother.

As the dies 50 and 52 apply pressure about the peripheral edge, RFenergy is applied through the dies 50 and 52, The combination of RFenergy and pressure softens the plastic material of the sheets 32 and34. The applied pressure causes the heat softened material of the sheets32, 34 to penetrate the interstices of the filtration medium 28,creating an interior matrix of sheet material commingled with filtrationmedium material. Within the matrix, the filtration medium melts,creating a composite seal 36.

At its surface, along the sheets 32 and 34, the seal 36 comprises mostlythe material of the sheets 32 and 34. With increasing distance from thesurface, the seal 36 comprises a commingled melted matrix of thematerial of the sheets 32 and 34 and the material of the filtrationmedium 28. This is believed to occur because the sheet material, whichis electrically heated and caused to flow by the applied radio frequencyenergy, is further caused by the applied pressure to flow into andpenetrate the interstices of the medium 28. The heated sheet materialthat flows under pressure into the interstices of the medium 28 causesthe medium 28 itself to melt about it.

After a brief period of cooling, the seal 36 sets and the dies 50 and 52are withdrawn. In a representative embodiment, the dies 50 and 52 arecoupled to a 4 KW radio frequency energy generator. Pressure of 60 PSIis applied, maintaining a die gap of 1.2 mm. A sealing time of about 5.5seconds is realized, followed by a cooling time of about 5 seconds.

As FIG. 8 shows, multiple sealed filter assemblies 56 can besequentially formed along the pre-assembly 48. The filter assemblies aredie cut into individual filters 20 (as shown by phantom lines 84 in FIG.8). The filter 20 is then integrated into a blood processing andcollection system 10, as shown in FIG. 1.

As FIGS. 6 and 7 show, when the port tubes 38 and 40 are to be locatedwithin the peripheral seal 36, the dies 50 and 52 can be provided withaligned concave recesses 58. The recesses 58 register to receive theport tubes 38 and 40. The dies 50 and 52 are brought together about theport tubes 38 and 40 and along the remaining periphery of thepre-assembly 48. Mandrels (not shown) are inserted into the tubes 38 and40 to prevent deformation of the tubes 38 and 40 while the seal 36forms. The mandrels are removed after the seal 36 cools.

Once integrated into the system 10, the flexible filter housing 30comprises a variable volume reservoir that can be used, afterfiltration, to receive residual air trapped in the transfer bag 18. Inthis arrangement, after leukocyte-depleted red blood cells have beentransferred from the filter 20 into the bag 18, residual air isexpressed from the transfer bag 18 back into the filter housing 30.Tubing upstream of the filter 20 can be clamped closed to trap air inthe filter housing 30. Being flexible, the housing 30 expands toaccommodate the residual air volume.

Alternatively, the residual air in the transfer bag 18 can betransferred back into the primary bag 12 through an air vent path thatbypasses the filter 20. For example, as FIG. 1 shows, a tubing path 60leads from the transfer bag 18 to the primary bag 12, through whichresidual air can be vented out of the transfer bag 18.

Instead of the tubing path 60 (see FIG. 9), an air bypass channel 62 canbe provided around the filter 20. An in-line one-way valve 64 can beplaced in the bypass channel 62, to prevent blood flow through thechannel in the direction toward the transfer bag 18. In anotheralternative arrangement (see FIG. 10), residual air in the transfer bag18 can be transferred into an air vent bag 66 through an integral airvent tube 68.

A flexible filter can be integrated in different ways into multipleblood bag systems. For example (see FIG. 11), a system 10′ like thatshown in FIG. 1 can include a second integral flexible filter 20′in-line between the primary bag 12 and the transfer bag 14. In thisarrangement, the filtration medium 28′ is selected to remove leukocytesfrom platelet-poor plasma prior to entering the transfer bag 14.

As another example, FIG. 12 shows a system 70 that includes a primarybag 72 and transfer bags 74, 76, 78. The primary bag 72 receives wholeblood from a donor. The whole blood is transferred from the primary bag72 through tubing 80 into the transfer bag 74. The tubing 80 carriesin-line an integral, flexible filter 82 of the type previouslydescribed. The filtration medium 84 is selected to remove leukocytesfrom the whole blood, without also removing platelets or red bloodcells. The leukocyte-depleted whole blood is centrifugally processed inthe transfer bag 74 into red blood cells and platelet-rich plasma, bothof which are in a leukocyte-depleted condition.

The transfer bag 76 receives the leukocyte-depleted platelet-richplasma, leaving the leukocyte-depleted red blood cells in the transferbag 74 for storage. The platelet-rich plasma is centrifugally separatedby conventional means in the transfer bag 76 into platelet concentrateand platelet-poor plasma. The platelet-poor plasma is transferred intothe transfer bag 78 for storage. This leaves the platelet concentrate inthe transfer bag 76, which serves as its storage container.

Various features of the invention are set forth in the following claims.

We claim:
 1. A blood filter device comprising first and second flexiblesheets, each sheet comprising a meltable material, a filter mediumcomprising a prefilter layer, a main filter layer, and a postfilterlayer, each layer comprising a meltable material, a peripheral sealformed by application of radio frequency heating and pressure in asingle step to join the first and second flexible sheets directly to thefilter medium and encapsulate the filter medium between the first andsecond flexible sheets, with the first flexible sheet overlying theprefilter layer, the second flexible sheet overlying the postfilterlayer, and the main filter layer sandwiched between the prefilter andpostfilter layers, the peripheral seal comprising a commingled meltedmatrix comprising material of the sheets and material of the filtermedium, an inlet port for conveying blood to the filter medium, anoutlet port for conveying blood from the filter medium, and the meltablematerial of the postfilter layer providing a fluid manifold effect forpassage of blood through the outlet port.
 2. A blood filter deviceaccording to claim 1 wherein the meltable material of the main filterlayer serves to remove leukocytes from blood by depth filtration.
 3. Ablood filter device according to claim 1 wherein the meltable materialof the prefilter layer serves to remove aggregations present in blood.4. A blood filter device according to claim 1 wherein the inlet port islocated in the first flexible sheet spaced from the peripheral. seal,and wherein the outlet port is located in the second flexible sheetspaced from the peripheral seal.
 5. A blood filter device according toclaim 1 wherein at least one of the inlet port and the outlet port islocated within the peripheral seal.
 6. A blood collection systemcomprising a container for holding blood, a blood filter device asdefined in claim 1 or 2 or 3 or 4 or 5, and tubing connecting the bloodfilter device to the container.
 7. A blood filter assembly comprising aplurality of blood filter devices, each as defined in claim 1, arrangedin series in an adjacent side-by-side relationship.